Wang David 4/A
4/A · RESPONSE BIOMEDICAL CORP · Filed Jun 21, 2012
Insider Transaction Report
Form 4/AAmended
Wang David
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-04-02+400,000→ 400,000 totalExercise: $0.11Exp: 2022-04-02→ Common Stock (400,000 underlying)
Footnotes (3)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2]100% of the options vest fully on the date which is one year after the date of grant.
- [F3]The options granted were subject to approval of shareholders and the Toronto Stock Exchange. Shareholders approval was obtained on June 19, 2012.